Clinical Trial Update: Fluorouracil and Low-Dose Suramin as Chemosensitization in Treating Patients With Metastatic Renal Cell (Kidney) Cancer [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update reporting completion of a Phase 1/2 study that evaluated fluorouracil with low-dose suramin as chemosensitization for metastatic renal cel…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• FLUOROURACIL (Fluorouracil)
• Suramin (suramin)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Recurrent Renal Cell Carcinoma, Stage IV Renal Cell Cancer | Phase 1, Phase 2 | Status: COMPLETED